First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac

Authors Janssen TM, Aitken K, Alongi F, Barry A, Bernchou U, Boeke S, Hall WA, Hosni A, Kroon PS, Nachbar M, Saeed H, Jürgenliemk-Schulz IM, Schytte T, Verkooijen HM, Nowee ME; tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium
Source Tech Innov Patient Support Radiat Oncol. 2022 May 10;22:50-54 Publicationdate 01 Jan 0001
Abstract

Abstract

The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.